| Characteristics and outcomes of COVID-19 in patients with autoimmune bullous diseases: a retrospective cohort study H Mahmoudi, AS Farid, A Nili, D Dayani, S Tavakolpour, T Soori, ... Journal of the American Academy of Dermatology 84 (4), 1098, 2021 | 33 | 2021 |
| Oral isotretinoin combined with topical clobetasol 0.05% and tacrolimus 0.1% for the treatment of frontal fibrosing alopecia: a randomized controlled trial H Mahmoudi, A Rostami, S Tavakolpour, A Nili, A Teimourpour, ... Journal of Dermatological Treatment 33 (1), 284-290, 2022 | 21 | 2022 |
| Rituximab in practice: clinical evaluation of patients with pemphigus after rituximab administration H Mahmoudi, S Tavakolpour, K Balighi, AS Farid, A Nili, D Jan, ... Dermatologic Therapy 34 (1), e14633, 2021 | 12 | 2021 |
| Adverse outcome and severity of COVID‐19 in patients with autoimmune bullous diseases: a historical cohort study FS Moghadam, N Kianfar, S Dasdar, R Samii, Z Farimani, PM Azar, ... Dermatologic Therapy 35 (9), e15672, 2022 | 11 | 2022 |
| Acute generalized exanthematous pustulosis with a focus on hydroxychloroquine: a 10-year experience in a skin hospital A Nili, E Zarei, A Ghamari, AS Farid, S Tavakolpour, M Daneshpazhooh, ... International Immunopharmacology 89, 107093, 2020 | 10 | 2020 |
| Current status and prospects for the diagnosis of pemphigus vulgaris A Nili, A Salehi Farid, M Asgari, S Tavakolpour, H Mahmoudi, ... Expert Review of Clinical Immunology 17 (8), 819-834, 2021 | 9 | 2021 |
| Evaluating the efficacy and safety of topical sirolimus 0.2% cream as adjuvant therapy with pulsed dye laser for the treatment of port wine stain: a randomized, double‐blind … M Fallahi, Z Hallaji, S Tavakolpour, S Niknam, A Salehi Farid, A Nili, ... Journal of Cosmetic Dermatology 20 (8), 2498-2506, 2021 | 9 | 2021 |
| Investigating expression pattern of eight immune‐related genes in pemphigus patients compared with the healthy controls and after rituximab therapy: Potential roles of CTLA4 … S Tavakolpour, H Mahmoudi, F Karami, S Elikaei Behjati, K Balighi, ... Dermatologic Therapy 33 (6), e14380, 2020 | 9 | 2020 |
| Oral simvastatin combined with narrowband UVB for the treatment of psoriasis: A randomized controlled trial M Al Salman, M Ghiasi, AS Farid, M Taraz, A Azizpour, H Mahmoudi Dermatologic Therapy 34 (5), e15075, 2021 | 8 | 2021 |
| Exacerbation of autoimmune bullous diseases after severe acute respiratory syndrome coronavirus 2 vaccination: is there any association? N Kianfar, S Dasdar, A Salehi Farid, K Balighi, H Mahmoudi, ... Frontiers in Medicine 9, 957169, 2022 | 7 | 2022 |
| Treatment of pemphigus patients in the COVID‐19 era: A specific focus on rituximab H Mahmoudi, S Tavakolpour, A Nili, AS Farid, M Daneshpazhooh, ... Dermatologic Therapy 33 (6), 2020 | 6 | 2020 |
| Factors associated with the healing time of pemphigus vulgaris oral lesions: A prospective study A Nili, S Karimi, A Salehi Farid, P Molhem Azar, Z Farimani, ... Oral Diseases 29 (5), 2248-2255, 2023 | 4 | 2023 |
| Comparing efficacy and safety of potassium hydroxide 5% solution with 5-fluorouracil cream in patients with actinic keratoses: a randomized controlled trial A Salehi Farid, S Niknam, K Gholami, S Tavakolpour, A Teimourpour, ... Journal of Dermatological Treatment 33 (3), 1376-1382, 2022 | 4 | 2022 |
| Pustular eruption after biosimilar rituximab infusion: report of acute generalized exanthematous pustulosis in two patients with pemphigus. M Daneshpazhooh, S Tavakolpour, A Salehi Farid, M Ebadi, A Nili, ... International Journal of Dermatology 61 (1), 2022 | 4 | 2022 |
| Paradoxical worsening of pemphigus after rituximab presenting as figurate bullous eruption H Mahmoudi, A Nili, A Salehi Farid, S Tavakolpour, M Daneshpazhooh British Journal of Dermatology 185 (1), e2-e2, 2021 | 3 | 2021 |
| Rituximab monotherapy in mild pemphigus A Nili, H Mahmoudi, N Heidari, S Tavakolpour, A Salehi Farid, K Balighi, ... Journal of Dermatological Treatment 33 (3), 1784-1786, 2022 | 2 | 2022 |
| Developing and characterizing locally delivered Nanobodies against PD-1 and CSF1R targeting innate and adaptive axis in the tumor microenvironment I Vogiatzi, A Lehmann, N Kanaya, L Moreno Lama, O Zwaenepoel, ... | | 2024 |
| Pemphigus Disease and Area Index: Unmet needs in the real‐world management of pemphigus H Mahmoudi, R Toosi, A Salehi Farid, M Daneshpazhooh Oral Diseases, 2023 | | 2023 |
| Nail abnormalities in subepidermal blistering diseases: a cross‐sectional study A Vafaeian, A Ghanbarzadeh, M Daneshpazhooh, R Abedini, K Balighi, ... International Journal of Dermatology 62 (6), 783-789, 2023 | | 2023 |
| Treatment Resistance to TNF‐α Inhibitors in Patients with Psoriasis A Gholami, A Vafaeian, M Daneshpazhooh, I Etesami, K Balighi, D Jan, ... Dermatologic Therapy 2023 (1), 7399468, 2023 | | 2023 |
Hamidreza MahmoudiAssociate professor of dermatology, Tehran University of Medical Sciences在 sina.tums.ac.ir 的电子邮件经过验证
